Skip to content
GenoLensGenoLens

MN1

Chr 22q12.1

MN1 proto-oncogene, transcriptional regulator

Aliases:
MGCR1-PEN, MGCR1
MANE:
ENST00000302326.5

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Fetal anomalies

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Intellectual disability

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Malformations of cortical development

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Monogenic hearing loss

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Disease associations (Open Targets)

  • CEBALID syndrome

    0.81
  • hereditary disease

    0.51
  • mathematical ability

    0.39
  • gastric adenoma

    0.37
  • carcinoma of liver and intrahepatic biliary tract

    0.37
  • endometrial endometrioid adenocarcinoma

    0.37
  • gastric carcinoma

    0.37
  • bile duct carcinoma

    0.37
  • breast ductal adenocarcinoma

    0.37
  • colorectal adenocarcinoma

    0.37

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Transcriptional activator MN1

Transcriptional activator which specifically regulates expression of TBX22 in the posterior region of the developing palate. Required during later stages of palate development for growth and medial fusion of the palatal shelves. Promotes maturation and normal function of calvarial osteoblasts, including expression of the osteoclastogenic cytokine TNFSF11/RANKL. Necessary for normal development of the membranous bones of the skull (By similarity). May play a role in tumor suppression (Probable)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.